...
首页> 外文期刊>Methods and Protocols >Efficient Ex Vivo Screening of Agents Targeting Thrombospondin1-Induced Vascular Dysfunction Using a Digital Multiwire Myograph System
【24h】

Efficient Ex Vivo Screening of Agents Targeting Thrombospondin1-Induced Vascular Dysfunction Using a Digital Multiwire Myograph System

机译:高效靶向血压出素1诱导的血管功能障碍的药剂的高效筛选

获取原文
           

摘要

Homeostasis of vascular tone is intricately and delicately maintained systemically and locally, by autonomic nerves and hormones in the blood and by intimal vasoactive substances, respectively. The balance can be acutely or chronically interrupted secondary to many alterations, especially under pathological conditions. Excessive matricellular glycoprotein thrombospondin 1 (TSP1) levels in circulation have been found to play an important role in ischemia-reperfusion injuries of different organs, by acutely suppressing vasorelaxation and chronically remodeling vascular bed. Our laboratory has been interested in identifying new drug moieties, which can selectively and effectively counteract TSP1-induced vascular dysfunction, in order to address associated clinical complications. Preliminary studies using computational docking and molecular models revealed potential drug candidates for further evaluation via vascular functional bioassay to prove the antagonism using an ex vivo vascular model. Herein, we described an efficient screening method for the identification of active drug candidates, by adapting a multiwire myograph system to perform a protocol with different treatments, in the presence of pathological levels of TSP1. We discussed the promising pharmacological evaluation results and suggested suitable modification for versatile applications. We also described the necessity of pre-determination of optimal resting tension to obtain the maximal response, if the experimental test model is different from those with determined optimal resting tension.
机译:血管间调的稳态是复杂的,在血液中的自主神经和血液中的自主神经和血液和血管血管活性物质的复杂性和局部地保持。平衡可以急性或长期中断次要的次要变化,特别是在病理条件下。已经发现过量的Matricellular糖蛋白1(TSP1)水平在不同器官的缺血再灌注损伤中发挥着重要作用,通过急性抑制血管插入和长期重塑血管床。我们的实验室一直有兴趣识别新的药物部分,可以选择性和有效地抵消TSP1诱导的血管功能障碍,以解决相关的临床并发症。使用计算对接和分子模型的初步研究揭示了通过血管功能生物测定的进一步评估的潜在药物候选者,以使用前体内血管模型来证明拮抗作用。在此,我们描述了一种有效的筛选方法,用于鉴定活性药物候选物,通过调整多励型识别系统,在TSP1的病理水平存在下进行具有不同治疗的协议。我们讨论了有前途的药理学评估结果,并建议适当的多功能应用修改。如果实验测试模型与具有确定最佳静止张力的最佳静止张力的那些,我们还描述了最佳静止张力预先确定最佳静止张力以获得最大响应的必要性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号